IRulya Therapeutics (IRLA) Assets (2018 - 2026)
IRulya Therapeutics (IRLA) recorded Assets of $124 million in Q2 2026, up 5.8% from $117.21 million a year earlier and up 365.7% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, IRulya Therapeutics reported Assets of $93.52 million, down 18.3% from FY2024.
- Annual Assets has a five-year compound annual growth rate of -13.2% (FY2020 to FY2025).
- Across earlier years, Assets came in at $114.48 million in FY2024 (-31.8%), $167.9 million in FY2023 (+61.6%), $103.91 million in FY2022 (-22.0%) and $133.23 million in FY2021 (-29.7%).
- The Q2 2026 figure is the highest quarterly Assets since Q3 2024.
- On a year-over-year basis, Assets rose in two of the last eight quarters, with an average decline of 16.3%.
- Peak year-over-year performance for Assets in the last five years was growth of 70.7% in Q1 2024, against a decline of 75.1% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $26.62 million (Q1 2026), $93.52 million (Q4 2025) and $109.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 119.92 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 124.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124.00 Mn |
| Mar 31, 2026 | 26.62 Mn |
| Dec 31, 2025 | 93.52 Mn |
| Sep 30, 2025 | 109.90 Mn |
| Jun 30, 2025 | 117.21 Mn |
| Mar 31, 2025 | 107.09 Mn |
| Dec 31, 2024 | 114.48 Mn |
| Sep 30, 2024 | 126.52 Mn |
| Jun 30, 2024 | 134.83 Mn |
| Mar 31, 2024 | 159.29 Mn |
| Dec 31, 2023 | 167.90 Mn |
| Sep 30, 2023 | 85.39 Mn |
| Jun 30, 2023 | 88.84 Mn |
| Mar 31, 2023 | 93.32 Mn |
| Dec 31, 2022 | 103.91 Mn |
| Sep 30, 2022 | 109.78 Mn |
| Jun 30, 2022 | 117.86 Mn |
| Mar 31, 2022 | 116.13 Mn |
| Dec 31, 2021 | 133.23 Mn |
| Sep 30, 2021 | 147.42 Mn |
API Access
IRulya Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();